{"id":"W2154581953","doi":"10.1016/s1470-2045(10)70151-0","title":"Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study","year":2010,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Adverse effect; Lung cancer; Clinical endpoint; Population; Chemotherapy; Surgery; Oncology; Phases of clinical research; Incidence (geometry); Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003614156,0.0002060481,0.0007323883,0.00009667119,0.0001075622,0.000006873547,0.0001650738,0.0001130978,0.0001319513],"category_scores_gemma":[0.00004883689,0.0001327551,0.00006012603,0.0002375488,0.0001270957,0.00003672417,0.0000384075,0.0003911415,0.000002562978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001783913,"about_ca_system_score_gemma":0.0004484588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009979252,"about_ca_topic_score_gemma":0.005359361,"domain_scores_codex":[0.9987611,0.00008208621,0.0003803495,0.0003135734,0.0001342411,0.0003286471],"domain_scores_gemma":[0.9986758,0.000437342,0.0001968688,0.0004992162,0.00009948945,0.00009127738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03870433,0.0244945,0.6029387,0.000491334,0.0008135745,0.0003462706,0.02580866,0.002945616,0.0306018,0.0000550244,0.0007306563,0.2720695],"study_design_scores_gemma":[0.3912926,0.01866634,0.5446686,0.0001936552,0.001228593,0.00003419171,0.001433823,0.01087546,0.006798821,0.00004460792,0.02426735,0.0004960247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911155,0.0007613528,0.0001379757,0.003660864,0.0002936719,0.002573418,0.00005343511,0.00002984649,0.001374007],"genre_scores_gemma":[0.9972053,0.0006327456,0.0005705137,0.000688128,0.0002535391,0.0003787373,0.00002913686,0.00002933659,0.0002126252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3525883,"threshold_uncertainty_score":0.5413596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02237964947975649,"score_gpt":0.3924690575272414,"score_spread":0.3700894080474849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}